[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Fulcrum Therapeutics Inc (FULC)

Fulcrum Therapeutics Inc (FULC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 281,536
  • Shares Outstanding, K 76,297
  • Annual Sales, $ 0 K
  • Annual Income, $ -74,880 K
  • EBIT $ -96 M
  • EBITDA $ -95 M
  • 60-Month Beta 3.05
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.92

Options Overview Details

View History
  • Implied Volatility 84.00% (-86.04%)
  • Historical Volatility 37.80%
  • IV Percentile 16%
  • IV Rank 10.07%
  • IV High 299.91% on 03/03/26
  • IV Low 59.82% on 06/03/26
  • Expected Move (DTE 8) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 25
  • Volume Avg (30-Day) 96
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 17,501
  • Open Int (30-Day) 17,666
  • Expected Range 3.72 to 3.72

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.13
  • Number of Estimates 5
  • High Estimate $-0.07
  • Low Estimate $-0.27
  • Prior Year $-0.31
  • Growth Rate Est. (year over year) +58.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.41 +9.09%
on 07/13/26
3.91 -4.86%
on 08/07/26
+0.22 (+6.29%)
since 07/10/26
3-Month
2.83 +31.45%
on 06/02/26
7.32 -49.18%
on 05/14/26
-3.24 (-46.55%)
since 05/12/26
52-Week
2.83 +31.45%
on 06/02/26
15.74 -76.37%
on 12/08/25
-2.82 (-43.12%)
since 08/12/25

Most Recent Stories

More News
Kaplan Fox Alerts Investors of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) to Possible Securities Law Violations

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

FULC : 3.72 (+0.81%)
Kaplan Fox Notifies Investors of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) of an Investigation Into Potential Securities Law Violations

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

FULC : 3.72 (+0.81%)
Kaplan Fox Encourages Investors of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) to Contact the Firm Regarding Potential Securities Law Violations

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

FULC : 3.72 (+0.81%)
Kaplan Fox Reminds Investors of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) of an Ongoing Investigation Into Potential Securities Law Violations

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

FULC : 3.72 (+0.81%)
Kaplan Fox is Investigating Fulcrum Therapeutics, Inc. (NASDAQ: FULC) for Potential Securities Law Violations - Investors Encouraged to Contact the Firm

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

FULC : 3.72 (+0.81%)
Kaplan Fox is Investigating Fulcrum Therapeutics, Inc. (NASDAQ: FULC) for Potential Securities Law Violations - Investors are Encouraged to Contact the Firm

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

FULC : 3.72 (+0.81%)
Kaplan Fox Announces an Investigation Into Fulcrum Therapeutics, Inc. (NASDAQ: FULC) for Potential Securities Law Violations

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

FULC : 3.72 (+0.81%)
Kaplan Fox Encourages Investors of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) to Contact the Firm to Learn About Their Legal Rights

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

FULC : 3.72 (+0.81%)
Kaplan Fox & Kilsheimer LLP Alerts Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Investors to a Securities Investigation

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

FULC : 3.72 (+0.81%)
FULC Investor Alert: Levi & Korsinsky Investigates Fulcrum Therapeutics, Inc. (FULC) for Potential Securities Fraud

Fulcrum Therapeutics, Inc. lost approximately half its market value after disclosing FDA safety concerns leading the company to discontinue its lead sickle-cell candidate.*

FULC : 3.72 (+0.81%)

Business Summary

Fulcrum Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on genetically defined diseases with an initial focus on rare diseases. Fulcrum Therapeutics Inc. is based in Cambridge, United States.

See More

Key Turning Points

3rd Resistance Point 3.89
2nd Resistance Point 3.82
1st Resistance Point 3.77
Last Price 3.72
1st Support Level 3.64
2nd Support Level 3.57
3rd Support Level 3.52

See More

52-Week High 15.74
Fibonacci 61.8% 10.81
Fibonacci 50% 9.28
Fibonacci 38.2% 7.76
Last Price 3.72
52-Week Low 2.83

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.